You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (59)

Journals (0)

1-10 of 59 results for first-generation EGFR-TKI

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Expert consensus on the use of third-generation EGFR-TKIs in EGFR-mutated advanced non-small cell lung cancer with various T790M mutations post-resistance to first-/second-generation EGFR-TKIs

Open access

Review article

First published 2024

Expert consensus on the use of third-generation EGFR-TKIs in EGFR-mutated advanced non-small cell lung cancer with various T790M mutations post-resistance to first-/second-generation EGFR-TKIs

Jietao Ma, Letian Huang, Chengbo Han

Therapeutic Advances in Medical Oncology

Select article: The Efficacy of First-Generation EGFR-TKI Combined With Brain Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With Brain Metastases and EGFR Sensitive Mutations: A Retrospective study

Open access

Research article

First published 2021

The Efficacy of First-Generation EGFR-TKI Combined With Brain Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With Brain Metastases and EGFR Sensitive Mutations: A Retrospective study

Yuting Liu, Juanjuan Wang, Jingjing Wu [...]

Technology in Cancer Research & Treatment

Select article: Potential biomarkers of primary resistance to first- and second-generation EGFR-TKIs in non-small-cell lung cancer: a real-world study

Open access

Research article

First published 2025

Potential biomarkers of primary resistance to first- and second-generation EGFR-TKIs in non-small-cell lung cancer: a real-world study

Jingyi Wang, Bolin Chen, Xingxiang Pu [...]

Therapeutic Advances in Medical Oncology

Select article: Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIs

Free access

Research article

First published 2021-5

Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIs

Oscar Arrieta, Juan-Manuel Hernandez-Martinez, Edgar Montes-Servín [...]

Cancer Biomarkers

Select article: The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study

Open access

Research article

First published 2021

The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study

Yen-Hsiang Huang, Jen-Yu Hung, How-Wen Ko [...]

Therapeutic Advances in Medical Oncology

Select article: Comparison of first and third generation EGFR-TKIs for the treatment of advanced non-small cell lung cancer: A real-world study

Retricted access

Research article

First published 2025

Comparison of first and third generation EGFR-TKIs for the treatment of advanced non-small cell lung cancer: A real-world study

Maitri Shah, Kashvi Shah, Hetvi Dave [...]

Journal of Oncology Pharmacy Practice

Select article: EGFR tyrosine kinase inhibitors in non-small cell lung cancer: treatment paradigm,current evidence,and challenges

Retricted access

Review article

First published 2021-10

EGFR tyrosine kinase inhibitors in non-small cell lung cancer: treatment paradigm,current evidence,and challenges

Arafat Tfayli, Razan Mohty

Tumori Journal

Select article: Treatment in EGFR-mutated Non-small Cell Lung Cancer: How to Block the Receptor and overcome Resistance Mechanisms

Retricted access

Review article

First published 2017-7

Treatment in EGFR-mutated Non-small Cell Lung Cancer: How to Block the Receptor and overcome Resistance Mechanisms

Claudia Proto, Giuseppe Lo Russo, Giulia Corrao [...]

Tumori Journal

Select article: Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation

Retricted access

Review article

First published 2018-7

Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation

Meredith K Bollinger, Amanda S Agnew, Gerard P Mascara

Journal of Oncology Pharmacy Practice

Select article: Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance

Free access

Review article

First published 2015-10

Clinical approaches to treat patients with non-small cell lung cancer and epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance

Alfredo Tartarone, Rosa Lerose

Therapeutic Advances in Respiratory Disease

1
2
3
•••
6
10 / page

Article type

Publication date

Subjects

Access